Navigation Links
Treating depression may improve recovery of heart rate variability following coronary syndromes
Date:9/3/2007

Patients with depression appear to have an impaired ability to recover their heart rate variability following acute coronary syndromes such as heart attack, a factor that could increase their risk of coronary death, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals. However, patients who are treated with antidepressants or whose mood lifts may experience more of an improvement in heart rate variability than those who are untreated or remain depressed.

Heart rate variability refers to the degree to which the heart rate changes from beat to beat in response to normal impulses. Low heart rate variability predicts death after myocardial infarction [heart attack], the authors write as background information in the article. It is reduced in depressed compared with non-depressed patients after myocardial infarction and has been proposed to be a mediator of the increased mortality associated with depression. In non-depressed patients who have an acute coronary episode, heart rate variability drops and then recovers substantially but not completely during the next few months.

Alexander H. Glassman, M.D., of the Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, and colleagues measured heart rate variability in 290 depressed patients an average of three weeks after they were hospitalized for acute coronary syndrome, a term encompassing heart events such as heart attack. The patients were then randomly assigned to take either the antidepressant sertraline or placebo for 24 weeks. After 16 weeks, 258 patients returned for a second heart rate variability reading. The severity of each participants depression and their clinical response to depression treatment also were measured on previously established scales.

At the beginning of the study, previous episodes of depression were associated with lower heart rate variability. A
'/>"/>

Contact: Dacia Morris
212-543-5421
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gene Therapy shows promise in treating Hemophilia
2. Treating Depression In Children Could Lead To Poor Bone Development
3. Treating Epilepsy With Surgery
4. Treating Autism More Effectively
5. Stem Cell Therapy Effective For Treating Heart Attacks
6. Treating Leukemia With Natural Cells
7. Treating eye pain eases migraine
8. Treating wounds without stitches
9. Treating varicose veins
10. Treating acne with laser
11. Ketoconazole 2% more effective in treating Seborrheic Dermatitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Older males saw their odds drop by 63 percent wi..., MONDAY, Nov. 23 (HealthDay News) -- Moderate-to... or tennis may help reduce stroke risk in older me...tudy included almost 3,300 men and women, average ...ine years. During that time, there were 238 stroke...
(Date:11/23/2009)... Dr. Bernadine Healy, first woman to head the age...DAY, Nov. 23 (HealthDay News) -- The fallout from ...n delay the start of routine mammogram testing for...e U.S. National Institutes of Health advising wome...powerfully ignore them, because unequivocally this...
(Date:11/23/2009)... ,, CENTERCITY,Minn.,Nov.23/PRNewswire/--Haz...treatmentcenter,todayannouncedtheleadershipteamfor...bedfacilityinNaplesisscheduledtoopeninlateMarch201...sforadults,includingafullarrayoffamilyandoutpatien...ecutivedirectorofHazelden,sfacilityinNaples,withBr...
(Date:11/23/2009)... ,, $4Million Alliance ProgramSupportsFut...nshipGuideAvailableat www.Allia n ceS ...ire-USNewswire/--"Mr.President,youcancountusin.Wit...lianceisproudtobeapartofEducatetoInnovate,"saidAdo...ceforHispanicHealth,afterattendingaWhiteHousemeeti...
(Date:11/23/2009)... ,, TUCSON,Ariz.,Nov.23/PRNewswire/--Cortiva...apyWorkshoponSunday,Dec.6from1-3p.m.attheschool,s6...ortunityforparticipantstolearnandpracticebasicmass...dCortivaInstituteTucsonisgrowingrightalongwithit,"...n. ,, Infact,theU.S.DepartmentofLabor,s2009-201...
Breaking Medicine News(10 mins):Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2
... Illinois will host a first-of-its-,kind celebrati...s and,friends. The BIG Night Out - Indulgence for...om 6:30 p.m. to 10:00 p.m. in the Great Hall of Ch...olates,scrumptious hors d,ouevres and martinis mad...
... /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals,...t signed amended,agreements with Smith & Nephew wo...icoat(TM) dressings with SILCRYST(TM) nanocrystall...o grant,NUCRYST exclusive manufacturing rights, pl...
... Oct. 1 UTC Power, a,United Technologies Corp. (N...ed Dome- Tech Group, a national energy consulting ...y. Financial terms were not disclosed. Dome-Tech ...d carbon footprint reduction, smart energy,procure...
...Capabilities that Help Patients Achieve Optimum He....,(Nasdaq: VTIV ) today announced that it has lau...Outcomes, with a focus on helping pharmaceutical,c... wins -,the healthcare providers, the pharmaceutic...
... Increasing New Jersey Life Sciences Jobs With ... PARSIPPANY, N.J., Oct. 1 Daiichi Sankyo, Inc. ha...s and rapidly increasing its,staffing since 2002 t...cal companies experiencing steady and sustained,gr...
...ty Awareness Month, WHITE PLAINS, N.Y., Oct. 1 M...h the March of Dimes to help give,every baby their...ternity,a national sponsor of the March of Dimes P...to save babies from,premature birth. "We are plea...
Other Medicine News:Health News:Y-ME Illinois Hosts the First-Ever 'BIG Night Out' - Indulgence for a Cause 2Health News:NUCRYST and Smith & Nephew Revise Agreements 2Health News:NUCRYST and Smith & Nephew Revise Agreements 3Health News:NUCRYST and Smith & Nephew Revise Agreements 4Health News:NUCRYST and Smith & Nephew Revise Agreements 5Health News:NUCRYST and Smith & Nephew Revise Agreements 6Health News:NUCRYST and Smith & Nephew Revise Agreements 7Health News:UTC Power Acquires Dome-Tech Group 2Health News:inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes 2Health News:inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 2Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 3Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 4Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 5Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 6Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 7Health News:Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize 8Health News:Motherhood(R) Maternity Joins March of Dimes to Give Babies a Healthy Start in Life 2
(Date:11/23/2009)...swire-FirstCall/--CordBloodAmerica,Inc.(OTCBulleti...tioncompany( http://www.cordblood-america.com )foc...iologicalinsurancepolicy,tofamiliesnationwideandin...nterviewwithCEOandco-founderMatthewSchisslerisnowa...p.tv/file/2875811 . ,, Intheinterview,Mr.Schiss...
(Date:11/23/2009).../PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VR...itspartnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willc...eongoingphase2btrialofRG7128,afirst-in-classnucleo...nichepatitisCvirus(HCV)infection.Thedecisionwasrea...ringCommittee(DMC)ofallavailablesafetydatafromthef...
(Date:11/23/2009)...PRNewswire-FirstCall/--RaptorPharmaceuticalCorp.("...edresultsfromaPhase2bclinicaltrialofitsproprietary...)inpatientswithnephropathiccystinosis("cystinosis"...nDiego("UCSD")GeneralClinicalResearchCenter,evalua...dynamicsofasingledoseofDRCysteamineinninecystinosi...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5FDA Panel Weighs Approving HPV Vaccine for Males 56544 1FDA Panel Weighs Approving HPV Vaccine for Males 56544 2FDA Panel Weighs Approving HPV Vaccine for Males 56544 3CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 1CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 2CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 3CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 4CONCERTA 28R 29 28methylphenidate HCI 29 LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS 56540 5Cash For Crows Feet Program Offers Effective and Affordable Laser Skin Treatments 56536 1Cash For Crows Feet Program Offers Effective and Affordable Laser Skin Treatments 56536 2
... Efficacy of Treating Patients with ...nd YONGIN-SI, South Korea, July 22 ,Jennerex, Inc....South,Korean partner Green Cross Corp., announced ...trial of its first-in-class lead product JX-594,de... resulted in clear,anti-cancer efficacy in patient...
...rapy and pegylated enzyme produces significantl... - - Pegylated enzyme well tolera...Inc. (Nasdaq: HALO ), a biopharmaceutical company... the extracellular matrix, today,announced the pre... data,for its pegylated-rHuPH20 enzyme (PEGPH20) a...
Other Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5
HSV 2 IgG II ELISA
Avci Foreign Body Forceps 20 gauge / 0.9 mm
Microforceps: Horizontal Subretinal
Microforceps: Claes ILM Forceps
Medicine Products: